Changes in retinal function and structure following intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment for diabetic macular edema (2015)
- Authors:
- USP affiliated authors: MESSIAS, ANDRÉ MÁRCIO VIEIRA - FMRP ; JORGE, RODRIGO - FMRP
- Unidade: FMRP
- Subjects: DOENÇAS RETINIANAS; EDEMA MACULAR CISTOIDE
- Language: Inglês
- Imprenta:
- Source:
- Título: Abstracts
- Conference titles: Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO)
-
ABNT
SOUSA, Monique Viana de et al. Changes in retinal function and structure following intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment for diabetic macular edema. 2015, Anais.. Rockville: ARVO, 2015. . Acesso em: 29 dez. 2025. -
APA
Sousa, M. V. de, Nepomuceno, A. B., Messias, A. M. V., Jorge, R., & Scott, I. U. (2015). Changes in retinal function and structure following intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment for diabetic macular edema. In Abstracts. Rockville: ARVO. -
NLM
Sousa MV de, Nepomuceno AB, Messias AMV, Jorge R, Scott IU. Changes in retinal function and structure following intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment for diabetic macular edema. Abstracts. 2015 ;[citado 2025 dez. 29 ] -
Vancouver
Sousa MV de, Nepomuceno AB, Messias AMV, Jorge R, Scott IU. Changes in retinal function and structure following intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment for diabetic macular edema. Abstracts. 2015 ;[citado 2025 dez. 29 ] - Ranibizumabe intravítreo no pré-operatório de vitrectomia em pacientes diabéticos com descolamento de retina tracional
- Diabetic macular edema treatment with bevacizumab vs. ranibizumab: a microperimetry study
- Intravitreal bevacizumab or triamcinolone combined with macular laser photocoagulation for diabetic macular edema: preliminary results
- Intravitreal ranibizumab for persistent new vessels in diabetic retinopathy
- Quality of life in patients with retinitis pigmentosa undergoing treatment with intravitreal bone marrow-derived stem cells (Reticell -clinical trial)
- ERG findings after one year intravitreal ranibizumab and single or multiple spot panphotocoagulation treatment for proliferative diabetic retinopathy
- Intravitreal autologous bone marrow derived stem cells in ischemic macular edema: results after 6 months follow-up
- Intravitreal injection versus sub-tenon S infusion of triamcinolone acetonide during cataract surgery in patients with refractory diabetic macular edema
- ERG findings after one year intravitreal ranibizumab and single or multiple spot panphotocoagulation treatment for proliferative diabetic retinopathy
- Multifocal ERG before and after pars plana vitrectomy in ILM peeling: one year follow-up
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
